SOLIGENIX, INC. — Regulatory Filings 2021

May 17, 2021

NT 10-Q 1 ea141233-nt10q_soligenix.htm NOTIFICATION OF LATE FILING

Field: Rule-Page

Field: /Rule-Page

SEC FILE NUMBER: 001-14778

CUSIP NUMBER: 834223307

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

Field: Rule-Page

Field: /Rule-Page

FORM 12b-25

Field: Rule-Page

Field: /Rule-Page

NOTIFICATION OF LATE FILING

(Check One):
For Period Ended: March 31, 2021
¨ Transition Report on Form 10-K
¨ Transition Report on Form 20-F
¨ Transition Report on Form 11-K
¨ Transition Report on Form 10-Q
For the Transition Period Ended:
___

Nothing in the form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

1

Field: /Page

PART I — REGISTRANT INFORMATION

Soligenix, Inc.

Full Name of Registrant

Field: Rule-Page

Field: /Rule-Page

Former Name if Applicable

29 Emmons Drive, Suite B-10

Address of Principal Executive Office ( Street and Number )

Princeton, NJ 08540

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

| x | The reasons described in reasonable detail in Part
III of this form could not be eliminated without unreasonable effort or expense; |
| --- | --- |
| (b) | The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

Due to a miscommunication between the management of Soligenix, Inc. (the “Registrant”) and the Registrant's EDGAR filing agency, the Registrant's Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 was filed after the 5:30 p.m. (Eastern Daylight Time) filing deadline on May 17, 2021 (the due date for such Form 10-Q). Such Form 10-Q was submitted to the Securities and Exchange Commission (the “SEC”) for filing after 5:30 p.m. on May 17, 2021 and is expected to be accepted by the SEC on May 18, 2021. Accordingly, the Company expects to file the subject quarterly report within the extension period.

Field: Page; Sequence: 2

2

Field: /Page

PART IV — OTHER INFORMATION

(1)	Name and telephone number of person to contact in regard to this notification — Jonathan Guarino, Chief Financial Officer, Senior Vice President and Corporate Secretary	(609)	538-8200
	(Name)	(Area Code)	(Telephone Number)
(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ¨ No
(3)	Is it anticipated that
any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof? ¨ Yes x No If so, attach an explanation
of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the
results cannot be made.

Field: Page; Sequence: 3

3

Field: /Page

SOLIGENIX, INC.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 17, 2021	/s/ Jonathan Guarino
Name: Title:	Jonathan Guarino Chief Financial Officer, Senior Vice President and Corporate Secretary

4

Field: Rule-Page

Field: /Rule-Page